New York, NY -- (SBWIRE) -- 12/26/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Automatic Data Processing (NASDAQ:ADP), Theravance Inc (NASDAQ:THRX), Akamai Technologies, Inc (NASDAQ:AKAM), Endo Health Solutions Inc (NASDAQ:ENDP)
Automatic Data Processing (NASDAQ:ADP) showed a volume of 599,584.00 shares by the end of last trade whereas the average volume of the stock remained 2.21 million shares. The stock opened the session at $79.78 but then moved to $80.22. At that price, the stock showed a positive performance of 0.35%. Automatic Data Processing, Inc. (ADP) is a provider of business outsourcing solutions. ADP offers a wide range of human resource, payroll, tax and benefits administration solutions from a single source. ADP is also a provider of integrated computing solutions to auto, truck, motorcycle, marine, recreational vehicle, and heavy equipment dealers throughout the world.
Will ADP Continue To Move Higher? Find Out Here
Theravance Inc (NASDAQ:THRX) opened the session at $34.31 and closed the session at $34.00. The stock showed a negative performance of -0.18% in previous trading session. Traded with volume of 595,002.00 shares in the prior session and the average volume of the stock remained 903,321.00 shares. Theravance, Inc. (Theravance) is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. The Company is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease,
Has THRX Found The Bottom And Ready To Gain Momentum? Find Out Here
Akamai Technologies, Inc (NASDAQ:AKAM) opened the session at $47.43 and closed the session at $47.73. The stock showed a positive performance of 0.46% in previous trading session. Traded with volume of 591,099.00 shares in the prior session and the average volume of the stock remained 2.14 million shares. The beta of the stock remained 0.41. Akamai Technologies, Inc. (Akamai) provides content delivery and cloud infrastructure services for the delivery of content and applications over the Internet. The Company’s solutions range from delivery of conventional content on Websites, to tools that support the delivery and operation of cloud-based applications, to live and on-demand streaming video capabilities all designed to help its customers interact with people accessing the Internet from myriad devices and locations around the world. The Company offers five solutions designed to meet the online business needs of its customers:
Why Should Investors Buy AKAM After The Recent Gain? Just Go Here and Find Out
Endo Health Solutions Inc (NASDAQ:ENDP) the stock decreased -0.39% and finished the session at $66.71. Traded with volume of 590,794.00 shares in the prior session and the average volume of the stock remained 2.15 million shares. The beta of the stock remained 0.96. Endo Health Solutions Inc. is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm , Opana ER, Voltaren Gel, Percocet , Frova , Supprelin LA, Vantas , Valstar and Fortesta Gel. The Company operates in four segments: Endo Pharmaceuticals, Qualitest, AMS, and HealthTronics. Through the Company's HealthTronics segment,
Will ENDP Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)